Alina Tomilova

Alina Tomilova

Auto-generated profile, based on publicly available information

Alina Tomilova

Endocrinology Research Centre

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
AGA. O. Gavrilova
A. O. Gavrilova
ASAnastasia Severina
Anastasia Severina
MSM. S. Shamhalova
M. S. Shamhalova
MSMarina Shestakova
Marina Shestakova
Diabetes mellitus (DM) and chronic kidney disease are the diseases that have exceeded epidemic thresholds in terms of prevalence all over the world. That made it possible to classify them as non-communicable epidemics of the XXI century. Diabetic nephropathy (DN) is implicated with high levels of disablement and mortality. Advanced glycation end products (AGE) play a key role in the progression of DN. Increased formation of AGE occurs due to hyperglycemia under the conditions of diabetes. Moreover, there are additional factors in DN that increase the elaboration of AGE, such as high levels of oxidative stress and decreased renal clearance which slows down the AGE excretion. Both immediate effects of AGE and interaction of AGE with its cell-bound receptor (RAGE) result in a сascade of events that lead to further progression of DN. Thus, the research of the new therapeutic approaches targeted on the AGE-RAGE system is of great interest to slow progression of DN and improve the prognosis.

25 January 2022 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
Alexander V. VorontsovAlexander V. Vorontsov
Alexander V. Vorontsov
DBD. M. Babaeva
D. M. Babaeva
VVV. P. Vladimirova
V. P. Vladimirova
TDT. A. Dubovitskaya
T. A. Dubovitskaya
AGA. O. Gavrilova
A. O. Gavrilova
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Клинико-рентгенологическая диагностика гипофизита: обзор литературы и собственные наблюдения

1 October 2023 in Physiological Genomics
Verified
Journal Article
Closed access
PMPavel A. Makhnovskii
Pavel A. Makhnovskii
ELEgor M. Lednev
Egor M. Lednev
AGAlina O. Gavrilova
Alina O. Gavrilova
NKNadia S. Kurochkina
Nadia S. Kurochkina
TVTatiana F. Vepkhvadze
Tatiana F. Vepkhvadze
DPDaniil Popov
Daniil Popov
In skeletal muscle of metabolically healthy subjects, a typical single meal normalized to body mass induces activation of various transcription factors, expression of numerous receptor tyrosine kinases associated with the insulin signaling cascade, and transcription regulators. In skeletal muscle of obese individuals without and with type 2 diabetes, this signaling network is poorly regulated at the transcriptional level, indicating dysregulation of the early gene response to a mixed meal.

7 December 2019 in Osteoporosis and Bone Diseases
Verified
Journal Article
Open access
PDF file
TGTatiana A. Grebennikova
Tatiana A. Grebennikova
AGAlina O. Gavrilova
Alina O. Gavrilova
ATAnatoly Tiulpakov
Anatoly Tiulpakov
NTNatalya V. Tarbaeva
Natalya V. Tarbaeva
ZBZhanna Belaya
Zhanna Belaya
ТНТюльпаков Анатолий Николаевич
Тюльпаков Анатолий Николаевич
Osteogenesis imperfecta (OI) is a hereditary connective tissue disorder. Main clinical manifestations include recurring pathological fractures and progressive skeletal deformation. Five types of OI are distinguished based on clinical symptoms. In most cases, the disease is caused by mutations in the COL1A1 and COL1A2 genes, leading to a defect of type 1 collagen synthesis, which is the main component of the bone matrix. Up to 5% of patients with OI have a mutation in IFITM5 gene, which leads to the development of OI type V. Approximately 150 cases of the OI type V are described in the literature, and mutation c.-14C T in IFITM5 gene is found in most of the cases. Only 5 patients have a c.119C T: p.S40L.mutation. Pathogenesis of OI type V is not fully understood. It is assumed that mutations in the IFITM5 gene cause impaired osteoblastogenesis, decreased bone mineral density and multiple low-traumatic fractures. There is probably a phenotype-genotypic correlation in cases with different mutations of the IFITM5. However, it is currently difficult to assess the relationship in view of the variability of the characters and the low prevalence of the OI type V. We present the first description in Russia of the clinical case of an adult patient with OI type V due to a rare mutation p.119C T: p.S40L in the IFITM5 gene.

1 February 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
AKAsker Y Khapchaev
Asker Y Khapchaev
AVAlexander Vorotnikov
Alexander Vorotnikov
OAOlga A. Antonova
Olga A. Antonova
MSMikhail Samsonov
Mikhail Samsonov
ESEkaterina Shestakova
Ekaterina Shestakova
VSVladimir Shirinsky
Vladimir Shirinsky
Saturated free fatty acids are thought to play a critical role in metabolic disorders associated with obesity, insulin resistance, type 2 diabetes (T2D), and their vascular complications via effects on the vascular endothelium. The most abundant saturated free fatty acid, palmitate, exerts lipotoxic effects on the vascular endothelium, eventually leading to cell death. Shear stress activates the endothelial AMP-activated protein kinase (AMPK), a cellular energy sensor, and protects endothelial cells from lipotoxicity, however their relationship is uncertain. Here, we used isoform-specific shRNA-mediated silencing of AMPK to explore its involvement in the long-term protection of macrovascular human umbilical vein endothelial cells (HUVECs) against palmitate lipotoxicity and to relate it to the effects of shear stress. We demonstrated that it is the α1 catalytic subunit of AMPK that is critical for HUVEC protection under static conditions, whereas AMPK-α2 autocompensated a substantial loss of AMPK-α1, but failed to protect the cells from palmitate. Shear stress equally protected the wild type HUVECs and those lacking either α1, or α2, or both AMPK-α isoforms; however, the protective effect of AMPK reappeared after returning to static conditions. Moreover, in human adipose microvascular endothelial cells isolated from obese diabetic individuals, shear stress was a strong protector from palmitate lipotoxicity, thus highlighting the importance of circulation that is often obstructed in obesity/T2D. Altogether, these results indicate that AMPK is important for vascular endothelial cell protection against lipotoxicity in the static environment, however it may be dispensable for persistent and more effective protection exerted by shear stress.

20 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ESEkaterina Shestakova
Ekaterina Shestakova
Iurii S. StafeevIurii S. Stafeev
Iurii S. Stafeev
YYYury Yashkov
Yury Yashkov
AYAnatoly Yurasov
Anatoly Yurasov
ATAlina Tomilova
Alina Tomilova
IDIvan Dedov
Ivan Dedov
Background: Bariatric surgery is known to induce weight loss and diabetes remission in patients with type 2 diabetes (T2D), but the exact mechanism of glycemic normalization needs to be defined. Methods: The study included patients with BMI ≥ 35 kg/m2, obesity history ≥ 10 years, and planned bariatric surgery. At baseline and 3 and 6 months after surgery, all patients underwent anthropometric measurements, body composition and blood tests (including insulin, glucagon, and incretins during oral glucose tolerance test (OGTT)), and hyperinsulinemic euglycemic clamp tests. Diabetes remission was defined if the person reached HbA1c < 6.5% after surgery and glucose-lowering therapy withdrawal. Results: The study included 86 patients, divided into groups with no diabetes (control group, n = 44) and T2D (n = 42). Most patients with T2D reached normoglycemia at 6 months. BMI and insulin resistance (according to M-index) decreased in T2D group comparably to people without diabetes. At 6 months, people with T2D at baseline had less insulin and GLP-1 secretion and higher glucagon level during OGTT when compared to the control group. Conclusions: We conclude that weight and insulin resistance reduction is sufficient for T2D remission. The absence of insulin, glucagon, and incretin restoration is not crucial for the glucose metabolism in the short-term, but it may explain the relapse of T2D years after bariatric surgery.